Lactobacillus rhamnosus sepsis associated with probiotic therapy in an extremely preterm infant: Pathogenesis and a

Ming-Chou Chiang1, Chyi-Liang Chen2, Ye Feng3

  • 1Division of Neonatology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan; Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taoyuan, Taiwan.

Insights

Probiotic Lactobacillus rhamnosus GG can cause sepsis in preterm infants, particularly catheter-related infections. Biofilm formation by this probiotic strain is a critical factor in developing sepsis, especially with glucose presence.

Area of Science:

  • Neonatal Medicine
  • Microbiology
  • Infectious Diseases

Background:

  • Necrotizing enterocolitis (NEC) is a severe complication in preterm infants.
  • Probiotics, like Lactobacillus rhamnosus GG (L. rhamnosus GG), are used to prevent NEC.
  • Safety concerns exist regarding probiotic use in preterm infants.

Observation:

  • A preterm infant receiving oral L. rhamnosus GG developed sepsis.
  • Blood and catheter tip cultures identified L. rhamnosus.
  • Genome sequencing confirmed isolates as L. rhamnosus GG (ATCC 53103), indicating a probiotic-related infection.

Findings:

  • The patient recovered after antibiotic treatment.
  • L. rhamnosus GG isolates demonstrated biofilm formation capabilities.
  • Biofilm formation was influenced by environmental factors and culture media.
  • A literature review revealed ~60% of L. rhamnosus GG sepsis cases in infants involved infected catheters.

Implications:

  • L. rhamnosus GG's biofilm-forming capacity is a critical factor in probiotic-related sepsis in preterm infants.
  • This highlights the need for careful safety monitoring of probiotics in vulnerable infant populations.
  • Understanding biofilm formation mechanisms is crucial for preventing probiotic-associated infections.
Abstract

Related Concept Videos